Simon Peter Gampenrieder
About
In The Last Decade
Simon Peter Gampenrieder
52 papers receiving 916 citations
Peers
Comparison fields: 5 of 72
- Oncology 654
- Cancer Research 318
- Molecular Biology 247
- Pulmonary and Respiratory Medicine 245
- Radiology, Nuclear Medicine and Imaging 234
Countries citing papers authored by Simon Peter Gampenrieder
This map shows the geographic impact of Simon Peter Gampenrieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Peter Gampenrieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Peter Gampenrieder more than expected).
Fields of papers citing papers by Simon Peter Gampenrieder
This network shows the impact of papers produced by Simon Peter Gampenrieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Peter Gampenrieder. The network helps show where Simon Peter Gampenrieder may publish in the future.
Co-authorship network of co-authors of Simon Peter Gampenrieder
This figure shows the co-authorship network connecting the top 25 collaborators of Simon Peter Gampenrieder. A scholar is included among the top collaborators of Simon Peter Gampenrieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Peter Gampenrieder. Simon Peter Gampenrieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 5 | |
| 7 | 151 | |
| 8 | 3 | |
| 9 | 26 | |
| 10 | 13 | |
| 11 | 4 | |
| 12 | 12 | |
| 13 | 6 | |
| 14 | 6 | |
| 15 | 1 | |
| 16 | Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis. | 31 |
| 17 | 57 | |
| 18 | 10 | |
| 19 | 22 | |
| 20 | 28 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.